Jing Li, PhD, is a Senior Scientist at CST, where she focuses on identifying and validating antibodies for targets of interest to cover cancer growth, metastasis, and therapy resistance. Dr Li received her PhD in Biochemistry from Purdue University, and completed postdoctoral training at Dana Farber Cancer Institute.
